1. Home
  2. GMM vs CNSP Comparison

GMM vs CNSP Comparison

Compare GMM & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

BUY

Current Price

$1.18

Market Cap

7.2M

Sector

N/A

ML Signal

BUY

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$4.90

Market Cap

8.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMM
CNSP
Founded
2017
2017
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
8.5M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
GMM
CNSP
Price
$1.18
$4.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 17.5K
3.1K
Earning Date
07-28-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 8.03
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$1.90
52 Week High
$5.79
$10.54

Technical Indicators

Market Signals
Indicator
GMM
CNSP
Relative Strength Index (RSI) 19.17 38.01
Support Level $1.17 $4.58
Resistance Level $1.25 $5.52
Average True Range (ATR) 0.14 0.21
MACD -0.04 -0.03
Stochastic Oscillator 17.07 23.53

Price Performance

Historical Comparison
GMM
CNSP

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital asset development for the metaverse industry. The Company leverages its proprietary Mofy Lab technology platform, which integrates three-dimensional (3D) reconstruction technology and artificial intelligence (AI) interactive technology, to create high-definition virtual versions of physical world objects, including humans, animals, and scenes. It provides comprehensive technology solutions to support virtual content production for use across movies, television series, animation, advertising, and gaming. The Company operates through Virtual Technology Services, which generates the majority of revenue, and Digital Asset Development and others.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Share on Social Networks: